To Top

Search By Topic

Biologics – Large Molecule

89 Articles available
Immuno-oncology

Genentech and Biothera to Assess Combination Cancer Therapy

PAO-M12-17-NI-010
Biosimilars

First Biosimilar to Treat Breast and Stomach Cancers Approved

PAO-M12-17-NI-007
Biosimilars

Boehringer Ingelheim’s Adalimumab Biosimilar Wins First EU Approval

PAO-M11-17-NI-045
Biologics

Collaboration Announced Between Takeda Pharmaceutical and Portal Instruments

PAO-M11-17-NI-035
Drug Development

Compugen Advances Lead Anti-TIGIT Monoclonal Antibody to Manufacturing

PAO-M11-17-NI-025
Business

Grand River Aseptic Manufacturing Announces Majority Investment by Arlington Capital Partners

PR-M11-17-NI-014
CAR T

Mustang Bio Sends CAR T Cell Therapy Line to College

PAO-M11-17-NI-003
Biologics

ADCs: The Future of Biologic Drugs

PAP-Q04-17-VP-001
Innovation

Moving Beyond Monoclonal Antibodies

PAP-Q4-17-FA-002
Innovation

Single-Use Operational Excellence Explained: Effective Lifecycle Management

PAP-Q4-17-CL-006
Cell Line Development

Abzena and UGA Team Up to Develop MS Therapeutic

PAO-M10-17-NI-033
Funding

Ventria Bioscience aids global fight against intestinal infections that threaten up to 400 million children a year

PR-M10-17-NI-008
Biosimilars

Amgen To Co-Develop Biosimilars for Chinese Market with Simcere Pharmaceutical Group

PAO-M10-17-NI-007
Biosimilar

FDA Approves First Biosimilar Treatment for Multiple Cancers

PAO-M09-17-NI-030
Acquisition

Catalent Acquires Cook Pharmica

PAO-M09-17-NI-028
Biosimilar

Another Biosimilar Gets FDA Nod

PAO-M09-17-NI-011
Partnership

Collaboration Seeks Novel Pancreatitis Therapies

PAO-M08-17-NI-037
Biologics

New FDA Draft Guidance on Manufacturing Changes for Biologics Issued

PAO-M08-17-NI-034
Capacity Expansion

Boehringer Ingelheim Expands Biologics Manufacturing Capacity in California

PAO-M08-17-NI-007
CDMO

Biopharmaceutical Manufacturing Goes Mainstream

PAP-Q2-17-FA-004
Excipients

Celanese on the Road to BIO: Excipients In Biologics

Dr. Donald Loveday – Customer Applications Director, Pharma and Medical, Celanese. View more about Celanese on the Road to BIO.

PTV-M06-17-CL-010
Biologics

Sanofi Will Increase Investments in Biologics

PAO-M06-17-NI-012
Biologics

Pharma Revs Up Cancer-Fighting CAR T-Cell Therapy

MCP-M06-17-NI-001
Biologics

The Road to Biologics’ Continued Success

PAP-Q2-17-EN-001
Biologics

Biologics: Driving Force in Pharma

PAP-Q2-17-NO-001
Biologics

Propagating a Full Spectrum of Services for ADC Development and Manufacture

PAP-Q2-17-CL-007
Biologics

Making Strides: Biologics Push Forward

PAP-Q2-17-FA-001
Biologic

Q: If You Could Have One Piece of Biologic Manufacturing Equipment Improved, What Would It Be and Why?

PAP-Q2-17-RT-001
//Fix for text overflow in cards